Pharmaceuticals & Biotech

Pipelines, trials, approvals, safety, manufacturing, and next‑gen therapies.

  • 7 Subtopics
  • 9 Tracked terms
  • Last 30 days Feed window
Search within this topic Ask AI about this topic All topics

Inside Pharmaceuticals & Biotech

Discovery & Preclinical Targets, assays, animal models, and early safety/tox studies before human trials. Clinical Trials (Phases I–IV) Design, endpoints, enrollment, interim reads, and post‑market surveillance. Approvals, Safety & REMS FDA/EMA decisions, boxed warnings, pharmacovigilance, and label changes. Generics & Biosimilars Access, interchangeability, litigation, and pricing dynamics for follow‑ons. Vaccines & Immunization Platforms (mRNA, viral vector), boosters, schedules, and cold‑chain supply. Cell & Gene Therapies CAR‑T, CRISPR, in vivo delivery, manufacturing, and long‑term follow‑up. Manufacturing & Supply APIs, sterile fill‑finish, shortages, and quality systems across the supply chain.

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Pharmaceuticals & Biotech


news18.com > agency-feeds > new-blockbuster-tuberculosis-vaccines-could-save-seven-million-by-2050-gavi-10332312.html

New 'blockbuster' tuberculosis vaccines could save seven million by 2050: Gavi

1+ hour, 17+ min ago   (207+ words) ...


wausaupilotandreview.com > 09/15/2026 > measles-case-confirmed-in-marathon-county-resident-after-out-of-state-travel

Measles case confirmed in Marathon County resident after out-of-state travel

27+ min ago   (473+ words) Where LOCALS Look First For News A Marathon County resident has been diagnosed with measles after being exposed while traveling outside Wisconsin, the Marathon County Health Department announced Tuesday. The county confirmed the case in partnership with the Wisconsin Department…...


finance.biggo.com > news > 5f94054a3e3bd9c4

Nouscom CEO Marina Udier: The Off-the-Shelf Cancer Vaccine That Could Outsmart Lynch Syndrome — BigGo Finance

7+ hour, 54+ min ago   (619+ words) When Nouscom CEO Marina Udier talks about the next frontier in cancer therapy, she is not describing a drug for tumors that already exist. She is describing a shot that could prevent them from forming in the first place — and…...


cidrap.umn.edu > anti-science > new-polls-highlight-tumbling-trust-measles-vaccine-safety-advice-doctors

New polls highlight tumbling trust in measles vaccine safety, advice from doctors

52+ min ago   (714+ words) Two new polls reveal cracks in both US and global trust in medicine, with one showing erosion in Americans’ belief that the measles vaccine is safe for children and another finding that just over half of people in 13 countries say…...


christiancountynow.com > news > 267762-42-of-measles-cases-in-kentucky-are-in-christian-county-20-reported-locally

42% of measles cases in Kentucky are in Christian County, 20 reported locally - Christian County Now

5+ hour, 53+ min ago   (342+ words) CHRISTIAN COUNTY, KY (CHRISTIAN COUNTY NOW) – As of Sept. 15, the number of confirmed measles cases in Christian County continue to be the highest centralized location in the state, according to Kentucky measles case data. 20 local residents have contracted measles in…...


docwirenews.com > videos > pfizer-every-insight-matters-hcp-information-from-industry-breast-summit

Pfizer – Every Insight Matters – HCP (Information from Industry) | Biomarker Navigator

43+ min ago   (17+ words) Pfizer – Every Insight Matters – HCP (Information from Industry) DocWireNews Pfizer – Every Insight Matters – HCP (Information from Industry)...


finance.yahoo.com > healthcare > articles > braff-group-advises-community-clinical-180700594.html

The Braff Group Advises Community Clinical Research on its Partnership with PhaseWell Research

1+ hour, 55+ min ago   (329+ words) Yahoo Finance Oops, something went wrong U.S. markets close in 29m The Braff Group Advises Community Clinical Research on its Partnership with PhaseWell Research PITTSBURGH, Sept. 15, 2026 /PRNewswire/ -- The Braff Group is pleased to announce that its client, Community Clinical Research ("CCR") in…...


allsci.com > news > licensing-and-partnerships > transcon-metabolic-rights-ascendis-to-regain-as

Novo exits Ascendis TransCon obesity deal, returning once-monthly semaglutide rights

6+ hour, 12+ min ago   (458+ words) AllSci The newly renamed Novo has terminated its metabolic and cardiovascular disease collaboration with Ascendis Pharma (Nasdaq: ASND), returning worldwide rights to TransCon technology-based programs including once-monthly TransCon Semaglutide, as per an announcement from Ascendis. The decision ends a partnership…...


tradingview.com > news > urn:summary_document_transcript:quartr.com:4172057:0-spro-sp001-targets-cd40-ligand-for-igg4-related-disease-with-phase-ii-trial-planned-for-2027

SPRO: SP001 targets CD40 ligand for IgG4-related disease, with phase II trial planned for 2027

1+ hour, 36+ min ago   (71+ words) TradingView SP001, a third-generation Fc silent anti-CD40 ligand antibody, shows promising preclinical and clinical data for immune-mediated diseases, especially IgG4-related disease. A phase II trial is planned for 2027, aiming to address unmet needs with a differentiated mechanism. Based on Spero Therapeutics,…...


ctmirror.org > 09/15/2026 > court-upholds-ct-law-no-religious-exemptions-school-vaccines

CT court upholds law: No religious exemptions to vaccines

47+ min ago   (682+ words) by Katy Golvala, CT Mirror September 15, 2026 A Superior Court judge in Stamford on Monday dismissed a lawsuit challenging a Connecticut law that eliminated religious exemptions from school vaccine requirements. In the 2022 lawsuit, Spillane vs. Lamont, two mothers from Orange and…...